Patients with schizophrenia exhibit deficits in automatic, preattentive sensorimotor gating (prepulse in hibition [PPI]) of the startle reflex.
C
ORE FEATURES OF SCHIZO phrenia include cognitive and emotional distur bances that may be linked to a disruption in the nor mal processing and/or hierarchical organi zation of sensory and cognitive informa tion. 1, 2 Furthermore, disturbances in perception, thought and language struc ture, and behavioral organization in schizo phrenia may result from impaired auto matic, preconscious inhibitory mechanisms that normally regulate the quantity and quality of sensory and cognitive informa tion that reaches consciousness. [2] [3] [4] [5] [6] The loss of information-protective mechanisms in schizophrenia is a feature of models span ning psychological and neurobiological do mains. 1, 3, 7, 8 Laboratory measures of defi cient inhibition are used to understand the neural and molecular mechanisms of schizophrenia [9] [10] [11] as biomarkers for drug de velopment 12 and as endophenotypes to identify schizophrenia genes. 13 Patients with schizophrenia are defi cient in 1 form of automatic, precon scious inhibition: sensorimotor gating as assessed by prepulse inhibition (PPI) of startle. 5, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Prepulse inhibition is the au tomatic suppression of startle magnitude that occurs when the startling stimulus is preceded 30 to 500 milliseconds by a weak prepulse. [31] [32] [33] Reduced PPI in schizophre nia is detected under specific experimen ‡Examples of medical or psychiatric conditions include history of electroconvulsive therapy, current substance abuse, and inappropriate diagnosis (schizoaffective disorder).
tal conditions and is among the most consistent and ro bust markers of brain-based inhibitory deficits in this disorder.
Less consistent is the evidence that this deficit in pre attentive sensorimotor inhibition contributes to symp tomatic, cognitive, or functional impairment in schizo phrenia. Studies 18, 34, 35 report weak or no significant correlations between PPI and symptom severity in schizo phrenia. Some evidence links deficient PPI to the core schizophrenia trait, rather than symptoms, or cognitive and functional impairment. 25, [36] [37] [38] [39] Others 19, 22, 23, 26, 29 re port deficient PPI only in symptomatic patients that par tially or completely resolves with medication treatment.
Several factors might account for conflicting evi dence linking PPI to clinical, cognitive, and functional deficits in schizophrenia. First, perhaps no such rela tionships exist; PPI deficits in schizophrenia might re flect brain processes that do not contribute to these other domains. Second, conflicting findings may reflect the fact that patient cohorts across studies range from outpa tient to inpatient to mixed samples whereas control co horts range from hospital or university employees to broader community samples. Third, conflicting find ings may reflect different experimental designs; PPI is highly sensitive to stimulus parameters, including pre pulse characteristics that differ substantially across pub lished studies 35, 40 in patients with schizophrenia. Fourth, most studies are adequately powered to detect group dif ferences in patients vs normal comparison subjects (NCSs) but not to detect symptom correlates of PPI in patients. This problem is exacerbated by "ceiling-level" symp toms and "floor-level" functioning in patients, resulting in restricted ranges that complicate correlational strate gies. Furthermore, patient cohorts differ in terms of fac tors that influence PPI, including sex distribution and menstrual phase, 34, [41] [42] [43] [44] medication status, 20 and smok ing history. 45 These influences, together with the het erogeneity of neural dysfunction in schizophrenia, add variance that-without large cohorts-might obscure the detection of clinical or symptom correlates of PPI.
In this study, PPI was measured in large cohorts of patients (n=103) and NCSs (n=66) to achieve the power necessary to definitively test the hypothesis that PPI defi cits in patients with schizophrenia are significantly re lated to measures of symptom severity, neurocognitive performance, and functional impairment and are mod erated by several specific variables, including sex, anti psychotic medications (APs), and smoking status.
METHODS
Patients with schizophrenia were referred by physicians and long-term care facilities and were carefully screened to rule out drug abuse or dependence and neurologic insults. After a de tailed description of study participation, written consent was obtained (University of California, San Diego, institutional re view board protocol number 040564). Diagnoses were con firmed using the Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition. 46 Normal comparison subjects an swered advertisements and underwent comprehensive clini cal interviews (via the Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition) 47 and toxicological screens to rule out Axis I or II diagnoses or cur rent recreational drug use. Audiometry (Saico Model SCR-2; Assens, Denmark) excluded subjects who could not detect 1-kHz 40-dB tones. Nonreactive subjects (mean startle magnitude �13.1 µV [10 digital units] in the first trial block containing prepulse trials) were excluded as per the article by Braff et al. 14 The recruitment target goal was 100 patients; the final sample included 103 patients and 66 NCSs.
Demographics and clinical characteristics of all of the par ticipants are shown in Table 1 and Table 2 . Compared with the final NCS group, the final patient group was older and had greater representation of men and smokers. Limited informa tion on menstrual dates was obtained from patients either based on the use of medications that prevented normal cycles 48 or because of grossly impaired self-reporting. Most patients were quite impaired, had longstanding illness, and were medicated with atypical APs. Symptoms were assessed with the Scale for the Assessment of Positive Symptoms (SAPS) 49 and the Scale for the Assessment of Negative Symptoms (SANS). 50 Neurocogni tive measures [51] [52] [53] [54] [55] [56] are listed in Table 3 . Functional status was assessed with the Global Assessment of Functioning (GAF) scale, 57 the University of California, San Diego, Performance based Skills Assessment (UPSA) scale, 58 the Scale of Function ing (SOF), 59 and the Level of Independent Living (LIL) scale. 60 The GAF scale 57 assesses overall function across psychologi cal, social, and occupational domains. The UPSA scale 58 measures performance in situations considered necessary for in dependent functioning: (1) general organization and planning; (2) finance; (3) social situations or communications; (4) trans portation; and (5) household chores. The SOF 59 assesses func ) categorizes in dependence in living: (1) living in a structured or semistruc tured setting, eg, long-term treatment facility or board and care facility; (2) living with family or requiring regular help from family, friends, or social services; and (3) living indepen dently in an apartment or house.
Subjects abstained from smoking for at least 20 minutes prior to testing. They sat in a recliner chair in a sound-attenuated room. Methods followed those in previous articles. 18, 21, 30 Two 4-mm silver-silver chloride electrodes were positioned below and lateral to each eye over the orbicularis oculi (resis tance�10 �), with a ground electrode behind the left ear. Elec tromyographic activity was directed through an SR LABORATORY monitoring system (San Diego Instruments, Inc, San Diego) that recorded 250-millisecond epochs starting with startle stimulus onset (1-kHz sampling rate); blink scoring pa rameters were described previously.
14 Electromyographic ac tivity was band-pass filtered (0.1-1.0 kHz). Startle stimuli were presented binaurally through headphones. The session in cluded a total of 74 active and 18 no-stimulation trials, lasted 23.5 minutes, and began with a 5-minute acclimation to white noise at a 70-dB sound pressure level that continued through out the session. Startle stimuli were 40-millisecond noise bursts at a 115-dB sound pressure level. Prepulses were 20 millisecond noise bursts 15 dB higher than background, with onset 30, 60, or 120 milliseconds prior to pulse onset. Five startle stimuli were presented at the beginning (block 1) and end (block 4) of the session to assess habituation. In blocks 2 and 3, pulse alone (PA) trials and each of the 3 prepulse trial types were pseudorandomly intermixed (range of intertrial intervals, 11-19 seconds; mean intertrial interval, 15 seconds). In 18 no stimulation trials, data were recorded without stimulus pre sentation to assess basal electromyographic activity (no sig nificant main or interaction effects were noted).
Multivariate repeated-measures analyses of variance (ANOVAs) with Greenhouse-Geisser corrections and Fisher protected least-significant difference post hoc comparisons were performed with diagnosis as a between-subject factor. For PPI percentage, 100 � (1 − [prepulse � pulse amplitude]/ [pulse amplitude]), within-subject factors were block and prepulse interval. Because no main or interaction effects of block or eye side were observed in analyses of PPI or reflex latency, data were collapsed across blocks and eye side. The relationships between PPI and clinical, neurocognitive, and functional variables were assessed using the 60-millisecond prepulse interval (where PPI deficits were detected) via con tinuous (regression) and categorical (median or quartile split) strategies. To examine key relationships independent from moderating effects of sex, medication, and smoking status on PPI, separate analyses were conducted on men and women, on subjects not receiving atypical APs, and on non smokers. Where inspection of the data revealed extreme val ues, analyses were confirmed using both nonparametric (eg, Spearman rank correlation, Mann-Whitney U test) and para metric (simple regression, ANOVA) analyses. In all cases, � =.05. Where appropriate, effect sizes (d) are reported. 61 
RESULTS

OMNIBUS ANALYSES
Results of startle and PPI measures are seen in Figure 1 . Analyses of variance of startle magnitude, habituation, and basal electromyographic activity revealed no signifi cant differences across diagnosis or sex. For startle mag 
14).
As expected, ANOVA of PPI revealed significant ef fects of sex (PPI in men�PPI in women) and prepulse interval (PPI with 120-millisecond prepulse interval�PPI with 60-millisecond prepulse interval�PPI with 30 millisecond prepulse interval) as well as significant inter actions of diagnosis�interval and diagnosis�sex�interval. There was no significant main effect of diagnosis and no other informative 2-, 3-, or 4-way interactions. Post hoc comparisons at each prepulse interval revealed signifi cantly greater PPI in NCSs than in patients only for 60 millisecond prepulse intervals (P�.04; d=0.24) ( Figure 1A ).
Based on a near-significant diagnosis � sex interac tion for startle magnitude, we compared PPI in sub groups that were closely balanced for startle magnitude by eliminating the extreme decile (10%) of startle mag nitude values from male and female NCSs and patients. These comparisons confirmed all of the significant main and interaction effects described earlier, including sig nificantly reduced PPI in patients with schizophrenia as compared with NCSs for 60-millisecond prepulse inter vals (P�.04).
MEDICATION
Patients were first classified as the following: not receiv ing medication (n=9); receiving typical APs (n =9); re ceiving atypical APs (n=67); and receiving both typical and atypical APs (n=18) ( Table 2 ). Analysis of variance of PPI revealed a significant effect of medication status (P�.001), reflecting increased PPI among patients re ceiving APs, and particularly among those receiving atypical APs, compared with patients not receiving medication (Figure 2A) . Analyses of variance detected no significant effects of medication on startle magni tude or habituation or on clinical or functional measures (all F�1).
Based on present and published 19, 20 evidence that atypi cal APs normalize PPI in schizophrenia and that PPI defi cits persist (although perhaps in an attenuated form) among patients receiving only typical APs, 5,14-24 a case-control matching strategy was used to analyze PPI in the 18 pa tients not receiving atypical APs. Each patient was matched to an NCS based on sex and age; if 2 NCSs met these char acteristics, both were included in the analysis. This com parison revealed PPI deficits in patients that were robust and independent of prepulse interval or sex. Analysis of variance of PPI revealed significant effects of diagnosis (PPI in NCSs�PPI in patients; P�.02) and prepulse interval, but there were no 2-or 3-way interactions.
Differences in PPI are most easily attributed to differ ent levels of sensorimotor gating when groups differ in the sensitivity of startle to inhibition by prepulses but do not differ in startle to PA stimuli. In this case-matched sample, it was easy to precisely balance groups for mean startle magnitude on PA trials ( Figure 2B ). Analysis of variance of startle magnitude across all trial types re vealed a significant interaction of diagnosis �trial type, reflecting higher startle magnitude on prepulse trials in patients than in NCSs despite identical mean startle mag nitude in patients and NCSs on PA trials. This provides definitive evidence for reduced sensorimotor gating in patients with schizophrenia; compared with their ef fects in NCSs, prepulses were significantly less effective in reducing the startle reflex in patients. 
CLINICAL SYMPTOMS
Regression analyses revealed no significant correlations of PPI percentage (at 60 milliseconds) with SANS or SAPS scores or with combined SANS and SAPS scores (0.00�all r�0.06). Owing to the presence of some extreme values in measures of PPI at 60 milliseconds, these findings were confirmed using a Spearman rank analysis (0.00���0.06). Because multiple factors apparently in fluenced PPI in this sample (Figure 4) , different ap proaches were used to isolate potential relationships be tween symptom severity and PPI. First, based on a significant difference in PPI in male patients vs female patients (43.73% vs 21.39%, respectively; P�.03), sepa rate analyses conducted in men and women detected no significant correlations between symptom scale scores and PPI percentage. Next, comparing PPI percentage among subjects with the lowest vs highest quartile of SANS scores, SAPS scores, and combined SANS and SAPS scores as well as comparing clinical scores among subjects with the low est vs highest quartile of PPI percentage revealed no sig (REPRINTED) nificant differences. Similar approaches limited to male or female patients not receiving atypical APs (n=18; male female ratio, 10:8) or nonsmokers (n = 32; male-female ratio, 26:6) yielded no significant relationships between symptom severity and PPI. Finally, ANOVAs of PPI us ing a median score split of each SANS and SAPS sub scale detected no significant relationship between PPI and low vs high scores.
NEUROCOGNITIVE MEASURES
Studies 42,66 have reported a weak or no relationship be tween neurocognitive performance and PPI in NCSs. We examined this relationship in patients and NCSs using the prepulse interval that detected maximal deficits (60 milliseconds) (Table 3 ). Parametric and nonparametric correlations revealed no significant relationships be tween PPI percentage and performance in any of the 17 primary neurocognitive variables. As with measures of clinical symptoms and function, we compared test scores in patients among the lowest vs highest quartiles of PPI percentage, and we compared PPI percentage among pa tients with the lowest vs highest quartiles of neurocog nitive scores. These 34 quartile analyses revealed no sig nificant differences.
Next, we assessed the relationship between neuro cognitive performance and PPI among patients, sepa rated from the effects of sex, medication, and smoking. Parametric and nonparametric correlations revealed no significant relationships between PPI percentage and any neurocognitive measure among 5 relevant subgroups of adequate size to test these relationships: (1) men; (2) women; (3) patients not receiving atypical APs; (4) nonsmokers; and (5) 
nonsmoking men (all P�.20).
Median and quartile split analyses of PPI and neurocog nitive measures also revealed no significant associations of higher PPI with higher neurocognitive performance among these 5 patient subgroups. In total, no signifi cant relationship between PPI and neurocognitive per formance was detected in more than 300 comparisons.
FUNCTIONAL MEASURES
Relationships between PPI deficits and GAF scale, UPSA scale, and SOF scores were first tested via parametric and nonparametric correlations and then by quartile analyses as performed for symptoms and neurocognitive scores. The relationship between LIL scale scores and PPI was tested among the extreme quartiles of PPI percentage using � 2 and Mann-Whitney U tests. Regression analyses using the full sample of 103 patients revealed no significant corre lations of PPI percentage with GAF scale, SOF, or UPSA scale scores. However, Spearman rank analysis revealed a significant correlation between PPI percentage and GAF scale score (P�.03) but not between PPI percentage and either SOF score or UPSA scale score; categorical com parisons revealed significantly higher GAF scale (but not UPSA scale or SOF) scores among patients in the highest quartile of PPI percentage than among those in the low est quartile (P�.05). Patients in the highest vs lowest quar tile of PPI percentage differed significantly in their LIL scale scores: 61.50% of patients in the upper PPI quartile lived independently compared with 30.77% of the patients in the lower PPI quartile (� 1 2 =5.53, P�.02; U=229, P�.05). We followed the same algorithm as described earlier to isolate a possible relationship between functional measures and PPI, separate from the influences of sex, medi cations, and smoking. Parametric and nonparametric correlations in male and female patients detected sig nificant relationships between GAF scale scores and PPI percentage in men (r =0.28, P�.02; � =0.341, P=.004) ( Figure 5A) but not women. Stratifying men based on GAF scale scores, ANOVA of PPI yielded a significant effect of GAF scale scores (P�.002) ( Figure 5B ship (higher PPI percentage among men in the higher GAF scale score quartile) was also highly significant (P�.001) ( Figure 5C This study detected reduced PPI in a large cohort of pa tients with schizophrenia compared with NCSs. This defi cit was statistically significant but small (d=0.24) and lim- patients who were not receiving atypical APs or were non scores were not collected from normal comparison subjects) ( Table 2 ). None of smokers. Prepulse inhibition was sexually dimorphic among patients with schizophrenia (PPI in men�PPI in women), as previously reported in NCSs. 34, [42] [43] [44] [45] The PPI deficits in patients were not related to clinical symptoms or performance on several neurocognitive measures, butparticularly among male patients-these deficits were sig nificantly related to 2 measures of long-term function.
Deficits in the automatic sensorimotor gating of startle have been described in patients with schizophrenia by many different groups. 35 A small number of studies have failed to detect PPI deficits in patients with schizophre nia using stimulus conditions (eg, low background noise and very high prepulse intensities relative to back ground) that differ substantially from those used in stud ies that detect deficits. 35, 67, 68 Also, many studies describ ing sensorimotor gating deficits in patients with schizophrenia vs NCSs have been inadequately pow ered to assess the potential impact of moderating vari ables on patterns of PPI deficits. The relevance of these moderating factors, including sex, APs, and nicotine, is underscored by findings in both preclinical and normal human studies. 19, 20, 23, [42] [43] [44] [45] 64, [69] [70] [71] Sex differences and menstrual cyclicity in PPI de scribed by several different groups 34, [42] [43] [44] [45] 72 have impor tant implications for the interpretation of PPI differ ences in schizophrenia vs NCS populations. As in the present study, open recruitment typically favors ascer tainment of male patients and female NCSs. Because men exhibit more PPI than women, this ascertainment bias artificially diminishes NCS vs schizophrenia group dif ferences. Menstrual cyclicity of PPI adds uncontrolled vari the 4 measures of function differed significantly among patients based on sex or medication status. Heavier smokers were more likely to live in structured or semistructured settings (P�.05) and have lower Scale of Functioning scores (P�.02). A, Regression analysis shows higher GAF scale scores associated with higher PPI percentages. B, Categorical comparison using analysis of variance shows an orderly increase in PPI across categories of increasing GAF scale scores. *P�.004 vs "41-50" and vs "�50." †P�.01 vs "41-50" and vs "�50" by Fisher protected least-significant difference. Numbers in each bar indicate the sample size; error bars, SEM. C, Comparisons using extreme quartiles. There were significantly greater GAF scale scores among patients in the highest quartile of PPI scores as compared with those in the lowest quartile (*P�.01) and significantly greater PPI percentages among patients in the highest quartile of GAF scale scores as compared with those in the lowest quartile ( †P�.001). Similar comparisons between PPI and Scale of Functioning or University of California, San Diego, Performance-based Skills Assessment scale scores in men (all or nonsmoking) detected no significant relationships, although in each of the 24 comparisons, the relationship was in the direction of greater PPI associated with better functional performance. Examination of the individual subscales among men revealed significant Spearman rank correlations between PPI and 4 Scale of Functioning items-orientation (P�.02), keeps appointments (P�.02), formulates realistic plans (P�.05), and less overall impairment (P�.04)-as well as the University of California, San Diego, Performance-based Skills Assessment subscale household chores (P�.03). Comparisons of PPI and Level of Independent Living scale scores in this group revealed significantly greater PPI among the most-independent functioning subjects as compared with the least-independent functioning subjects (P�.05) and significantly more independent living among subjects in the highest PPI quartile as compared with those in the lowest PPI quartile (� 1 2 =6.47, P�.02). Error bars indicate SEM.
ance that may differentially affect NCS vs patient samples based on hormonal effects of APs. 48 Nevertheless, PPI defi cits have been described in both male and female pa tients with schizophrenia. 18, 30 Lower PPI in female pa tients as compared with PPI in male patients has implications for studies attempting to assess clinical or functional correlates of PPI in schizophrenia: sex differ ( 
The initial report 5 of PPI deficits in patients with schizo phrenia predated the use of atypical APs. Preclinical stud ies later demonstrated that in addition to preventing the PPI-disruptive effects of various experimental manipu lations, atypical APs also enhance baseline PPI in some rodent strains and species. 12 Subsequent clinical re ports 19, 20, 23, 73 have suggested that atypical APs are asso ciated with greater and potentially normalized PPI lev els in patients with schizophrenia. In the present study, only 17% of patients were not being treated with atypi cal APs. Clearly, if atypical APs increase PPI in some groups of patients, the result of such pervasive use of atypi cal APs in patients with schizophrenia (or other popu lations, eg, patients with Tourette syndrome 74, 75 ) will be to diminish or eliminate the ability to detect PPI deficits between patients and NCSs. The present findings sup port the notion that PPI deficits in patients with schizo phrenia can be masked by atypical APs. Some stud ies 20, 73 also suggest that these deficits are partially normalized by typical APs, and the present findings are consistent with these articles (Figure 2A) . Because an over whelming number of patients with schizophrenia are cur rently treated with atypical APs, it is possible that PPI deficits in this population are a vanishing biomarker. Al ternative strategies for understanding the biology and clini cal implications of deficient sensorimotor gating have become increasingly important, including the use of optimized stimulus features (eg, 60-millisecond pre pulse intervals [see later], broadband stimuli, and promi nent background noise 21 ), unmedicated patients with schizophrenia 25, 29 and schizophrenia spectrum, 36,37 and populations of low-gating NCSs. 76 Antipsychotic medication use was not associated with reduced startle magnitude in this study. Short-term ad ministration of APs depresses startle in rodents 11 and hu mans 35 whereas startle-reducing effects of sustained AP exposure are less consistent. 35, 77 Progating effects of nicotine are described in measures of both PPI and P50 event-related potential sup pression. [62] [63] [64] 78, 79 If nicotine use per se is associated with increased PPI, then greater smoking among patients with schizophrenia would be expected to diminish group dif ferences in PPI measures. However, nicotine has com plex pharmacological effects characterized by rapid shifts in both blood levels and states of receptor sensitization that can influence PPI. 41, 64, 70 Because studies cannot eas ily control for the time interval between PPI testing and smoking, the amount smoked, smoking history, or the interindividual differences in nicotine receptor sensitiv ity, the impact of smoking on PPI is to increase uncon trolled variance. In this study, adequate power to com pare nonsmoking patients (particularly men) vs nonsmoking NCSs revealed group PPI differences (PPI in NCSs�PPI in patients) with greater group separation than was observed across the inclusive group of smok ers and nonsmokers. Furthermore, among patients, PPI was significantly greater among heavier smokers.
Despite the potent PPI-enhancing effects of atypical APs and nicotine in patients with schizophrenia, PPI defi cits at the 60-millisecond prepulse interval were detect able in the full cohort of 103 patients. This pattern sug gests that PPI deficits at the 60-millisecond interval are most resistant to the normalizing effects of APs and nico tine, consistent with the fact that 60 milliseconds is the interval at which PPI deficits are most often reported in medicated patients with schizophrenia. 5, 14, 20, 23, 30, 35 Stud ies [80] [81] [82] have described differences in the sensitivity of short-vs long-interval PPI to specific pharmacological interventions in rats, and it is conceivable that the 60 millisecond interval might be one that is least sensitive to progating effects of certain neurochemical influences in humans. Reflex inhibition 60 milliseconds after a pre pulse appears to be regulated by processes at the bound ary between automatic and attentionally sensitive inhi bition. 83 In other words, this temporal domain of inhibition sits at a transitional point between information that is regu lated automatically and that which can be manipulated volitionally. Theoretical models have proposed that this transitional zone between consciously accessible and unconscious processing is of particular importance for regulating the contents of consciousness and may also be an epoch of particular vulnerability in psychopatho logical states. 6, [84] [85] [86] [87] [88] The fact that sensorimotor gating at 60-millisecond prepulse intervals remains impaired (as do function and quality of life) despite the impact of atypical APs and nicotine suggests that gating at this in terval may be of particular importance to the biology of schizophrenia.
Studies 18, 34, 35 have reported weak or no correlations between symptom severity and PPI in patients with schizo phrenia. Smaller studies from our group have either de tected 18 or failed to detect 89 significant correlations be tween PPI percentage and SAPS and SANS scores in male patients with schizophrenia. With the large cohort of pa tients in this study, no simple relationship could be de tected between PPI and positive or negative symptom se verity or age among the full sample or in subgroups of nonsmokers and patients not receiving atypical APs. Cer tainly, there are many symptoms of schizophrenia that are not the focus of the SAPS or SANS that might correlate significantly with PPI. 89, 90 A preliminary qualitative article by Butler et al 91 noted a trend toward greater tactile (but not acoustic) PPI among 6 (predominantly male) patients with schizophrenia and low levels of Wisconsin Card Sorting Test perseverative responses than among 9 (predominantly female) pa tients distinguished by high levels of Wisconsin Card Sort ing Test perseverative responses. We observed no such trend with acoustic PPI in the present study. Karper et al 90 reported a significant negative correlation between right-eye-blink 120-millisecond acoustic PPI and later alized attention in a Posner task, and Perry and Braff 89 reported a significant negative correlation between right eye-blink 120-millisecond acoustic PPI and a Rorschach based measure of thought disorder. The lack of Posner and Rorschach measures in the present study makes it difficult to compare those findings with our own. None theless, our failure to detect a relationship between PPI and performance across neurocognitive measures was not for lack of trying; numerous strategies were used to try to find some association of PPI and neurocognition. At least 2 conclusions follow from these definitively nega (REPRINTED) A significant relationship with PPI was detected with 2 functional measures across the entire cohort of pa tients: the GAF scale and the LIL scale. Significant rela tionships between PPI and GAF scale scores were evi dent only in nonparametric or categorical analyses using ranks or extreme quartiles of PPI. Similarly, the relation ship between low PPI scores and limited independence of living was detected only among the extreme quartiles of PPI. Given the sensitivity of PPI to a number of po tentially confounding moderating factors, it is striking that any relationship could be detected between PPI and global measures of functioning among this heterog eneous group of patients. For example, the least independent patients (who had the lowest PPI) were the heaviest smokers, and heavier smoking was associated with higher PPI. Not surprisingly, few robust relation ships have been identified in the literature between func tioning and performance in a wide range of neurocog nitive and electrophysiological measures. 92, 93 In sharp contrast, when analyses were restricted to male patients, the relationships between PPI and scores on the GAF and LIL scales were relatively robust and consis tent: higher PPI was associated with better functioning. Because both the GAF scale and the LIL scale use a single score, it was not possible to characterize the specific do mains of functional strengths-beyond the important abil ity to live independently-that were associated with higher levels of PPI in male patients. However, both the SOF and UPSA scale involve composite ratings, and post hoc exploratory analyses suggested positive relationships with PPI: the abilities to keep appointments, formulate real istic plans, and complete household chores. These skills would appear to share common elements of effective se quencing or planning, which were not assessed directly by any of the neurocognitive measures in the present test battery. Because PPI deficits did not correlate signifi cantly with these neurocognitive measures, the associa tions between function and neurocognition on the one hand (Table 3) and between function and sensorimotor gating on the other ( Figure 5 ) appear to reflect different and perhaps independent pathways.
A reduction in the motor-inhibitory effectiveness of prepulses is seen clearly in the present study among pa tients not receiving atypical APs ( Figure 2B) . A similar observation was made in the first article 5 describing PPI deficits in patients with schizophrenia. At an empirical level, this finding demonstrates that for 30 to 120 mil liseconds after stimulation, the central nervous system in patients with schizophrenia is more responsive to a second stimulus than the central nervous system in nor mal individuals. At a conceptual level, this state of defi cient time-locked, automatic inhibition might put the in formation contained in the initial stimulus at greater risk to be degraded and therefore to not enter a hierarchical process that would lead to its appropriate cognitive or behavioral consequence. We do not know the real world consequences of inhibitory deficits detected in labo ratory measures of PPI, but evidence suggests that in some cases, PPI deficits might reflect processes associated more generally with a loss of protection of cognitive, sensory, or motor information. 74, 89, 94, 95 The present findings con firm that in patients with schizophrenia, PPI deficits are associated with specific measures of global, longstand ing functional impairment.
Slowed reflex latency among patients with schizo phrenia has not been uniformly detected in other stud ies 5, 14, 18 but has been detected in other chronic neuro psychiatric disorders. 94 The strong positive relationship between latency and age in patients but not NCSs sug gests that relatively caudal portions of the acoustic startle circuitry might be sensitive to processes associated with the chronicity of schizophrenia-either direct effects of the illness or sustained exposure to medications. Changes associated with increased latency in patients appear to be distinct from those associated with reduced PPI because these variables do not correlate significantly in patients and are related to different clinical factors (PPI: smoking, medications, functional status; latency: age, SAPS score), although both variables are sexually dimorphic (PPI in men�PPI in women; latency in women�latency in men).
The ability to detect PPI deficits in patients with schizophrenia is greatly enhanced by strategies that re move sources of uncontrolled variance (eg, sex differ ences and uncontrolled effects of menstrual cyclicity on PPI) and that exclude factors known to enhance PPI (eg, atypical APs and nicotine use). Future studies us ing PPI as a biomarker for neurobiological studies or as an endophenotype for genetic analyses need to carefully consider these moderating variables, together with the known sensitivity of PPI to stimulus parameters and ex perimental conditions, to maximize the utility of PPI for understanding the neurobiology, genetics, and treatment of schizophrenia. Table 2 and Figure 2A . In Table 2 , the third entry under the column heading "Characteristic" should have read, "Psychiatric hospitalizations, mean (range), No." In Figure 2A , the lengths of the error bars have been cor rected. The corrected Figure 2 and its legend are printed here in their entirety. Compared with PPI among NCSs, PPI was significantly reduced among unmedicated patients (*P�.001 by Fisher protected least-significant difference) and among all patients not receiving an atypical AP (P=.001); these effects were independent of prepulse interval (all P�.01 for 30-, 60-, and 120-millisecond intervals). Error bars indicate SEM. †P�.005 vs no AP. ‡P�.001 vs no AP. B, Mean startle magnitude on pulse-alone and combined prepulse and pulse trials in patients not receiving atypical APs and case-matched NCSs; groups were balanced precisely for startle magnitude on pulse-alone trials by omitting 1 subject whose startle magnitude on pulse-alone trials was 4. 
